Russian synthetic ACTH(4-10) analog studied for nootropic and neuroprotective effects.
Semax is a heptapeptide analog of ACTH(4-10) developed in Russia, used clinically there for stroke and cognitive disorders. Preclinical studies report BDNF / NGF upregulation.
Semax is a synthetic heptapeptide based on a fragment of adrenocorticotropic hormone, ACTH(4-10), modified for stability. It was developed in Russia, where it is used clinically for stroke and cognitive disorders.
Unlike full ACTH, Semax does not activate the stress (HPA) axis; instead, preclinical research focuses on its reported induction of neurotrophic factors such as BDNF and NGF. Outside Russia it is not FDA-approved and the controlled-trial base is limited.
BDNF / NGF induction; melanocortin signaling without HPA activation.
Behind every vial of Semax is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Semax, specifically, is brought into being.
On paper, Semax is C37H51N9O10S — about 813.9 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Assembling Semax means roughly 7 coupling cycles on the synthesizer — one protected residue added at a time, which is also 7 chances for an incomplete coupling to seed a deletion impurity. It is a short sequence, which makes the build comparatively tractable — but short does not mean trivial, and purity is still won or lost downstream.
The crude mixture — Semax plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one. It also contains oxidation-prone methionine or tryptophan residues, another family of impurities the chromatography has to resolve away.
A real batch of Semax proves itself: identity confirmed by mass spectrometry against its ~813.9 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Semax — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Producing Semax to a genuine purity spec means solid-phase synthesis, preparative HPLC purification, and batch quality control — none of it cheap, and none of it something you can verify by eye.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Semax is a synthetic ACTH(4-10) analog studied for nootropic and neuroprotective effects, used clinically in Russia for stroke and cognitive disorders.
Research points to induction of neurotrophic factors (BDNF, NGF) and melanocortin signaling, without activating the stress axis.
No — it is approved and used in Russia but is a research compound elsewhere. This page is a research and educational reference.
Ischemic stroke recovery, cognition, and neuroprotection, with most controlled data from Russian clinical use.
Synthetic heptapeptide analog of tuftsin investigated as an anxiolytic.
ViewEndogenous nonapeptide first isolated for its sleep-promoting properties.
ViewA 9-amino-acid cyclic hormone of labor and bonding — historically the first peptide hormone ever chemically synthesized, and the most over-marketed "love hormone."
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.